Therapeutic Asset Ratings
19,639 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ETOPOSIDE
Recurrent Childhood Kidney Neoplasm
Centre Oscar Lambret
P2
BB
(68)
Evomela
Graft Versus Host Disease
City of Hope Medical Center
P2
BB
(68)
Evomela
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
City of Hope Medical Center
P2
BB
(68)
FILGRASTIM
Extensive Stage Small Cell Lung Cancer
Zhou Chengzhi
P2
BB
(68)
FILGRASTIM
Hematopoietic And Lymphoid Cell Neoplasm
St. Jude Children's Research Hospital
P2
BB
(68)
FILGRASTIM
Myeloid Leukemia
M.D. Anderson Cancer Center
P2
BB
(68)
Fludarabine
Bone Marrow Disorder
Fred Hutchinson Cancer Center
P2
BB
(68)
Fludarabine
Inborn Errors of Metabolism
Washington University School of Medicine
P2
BB
(68)
Fludarabine
Oropharyngeal Carcinoma
HRYZ Biotech Co.
P2
BB
(68)
Fludarabine
Post-Transplant Lymphoproliferative Disease
City of Hope Medical Center
P2
BB
(68)
Fludarabine
Precancerous Condition
Institut Paoli-Calmettes
P2
BB
(68)
FLUDEOXYGLUCOSE
Breast Carcinoma
University of Washington
P2
BB
(68)
FLUDEOXYGLUCOSE
Stage IV Renal Cell Cancer
Rahul Aggarwal
P2
BB
(68)
FLUOROURACILUM
Adenocarcinoma
University of Chicago
P2
BB
(68)
FLUTICASONE
Stage IV Breast Cancer
Mayo Clinic
P2
BB
(68)
FULVESTRANT
Invasive Breast Carcinoma
Massachusetts General Hospital
P2
BB
(68)
Gdc-0449
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
BB
(68)
Golidocitinib
Non-Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
P2
BB
(68)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Recurrent Rectal Carcinoma
SWOG Cancer Research Network
P2
BB
(68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHD
P2
BB
(68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
HIV Infectious Disease
City of Hope Medical Center
P2
BB
(68)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoma, T-Cell
Memorial Sloan Kettering Cancer Center
P2
BB
(68)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER
Malignant Pancreatic Neoplasm
Baki Topal
P2
BB
(68)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Plasma Cell Myeloma
Sanofi
P2
BB
(68)
Inno-206
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P2
BB
(68)
Showing 376 to 400 of 19,639 assets
Previous
Page 16 of 786
Next